Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 2Behavior 1

Interventions

Carboplatin 106Pemetrexed 74Paclitaxel 58Cisplatin 52Erlotinib Hydrochloride 51Radiotherapy 49Docetaxel 43Gemcitabine 41Bevacizumab 41pembrolizumab 30Nivolumab 25Radiosurgery 21Etoposide 20durvalumab 13Cetuximab 13Specimen Handling 12Ipilimumab 12Magnetic Resonance Spectroscopy 11Gefitinib 11Vinorelbine 10Taxes 10Radiation 10Albumin-Bound Paclitaxel 10osimertinib 9Biopsy 9vandetanib 8Topotecan 7Platinum 7Irinotecan 7Drug Therapy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Lung Neoplasms × Transportation × Clear all
NCT06628167 2026-03-24

LCS II

Abramson Cancer Center at Penn Medicine

Phase NA Completed
252 enrolled 7 charts
Thoracic

Lung Neoplasms

NCT06207435 2025-09-02

LCS

Abramson Cancer Center at Penn Medicine

Phase NA Completed
242 enrolled 8 charts
Thoracic

Behavior, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡